Abstract
Substitution treatment is a therapeutic option that includes the prescription of agonist substances as an adjunct to medical and psychosocial care. The indication and the duration of treatment are determined on the basis of an individual assessment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Ali R, Auriacombe M, Casas M, Cottier L, Farrell M, Kleiber D, Kreuzer A, Ogborne A, Rehm J, Ward P (1998) Report of the external panel on the evaluation of the swiss scientific studies of medically prescribed narcotics to drug addicts. Report to the World Health Organization, Geneva
Arif A, Westermeyer J (1990) Methadone maintenance in the management of opioid dependence. An international review. Praeger, New York
Ball JC, Ross A (1991) The effectiveness of methadone maintenance treatment. Springer, Berlin Heidelberg New York
Bammer G, Dobler-Mikola A, Fleming PH, Strang J, Uchtenhagen A (1999) The heroin prescribing debate: integrating science and politics. Science 284: 1277–1278
Bühringer G, Gastpar M, Heinz W, Kovar KA, Ladewig D, Naber D, Täschner KL, Uchtenhagen A, Wanke K (1995) MethadonStandards. Vorschläge zur Qualitätssicherung bei der Methadonsubstitutionim Rahmen der Behandlung von Drogenabhängigen. Enke, Stuttgart
Bundesamt für Gesundheit (1985) Methadonbericht. Suchtmittelersatz in der Behandlung Heroinabhängiger in der Schweiz. Bundesamt für Gesundheit, Bern
Caplehorn JR (1994) A comparison of abstinence-oriented and indefinite methadone maintenance treatment. Int J Addict 29: 1361–1375
Chutuape MA, Silverman K, Stitzer ML (1998) Survey assessment of methadone treatment services as reinforcers. Am J Drug Alcohol Abuse 24: 1–16
**Cooper JR, Altman F, Brown BS, Czechowicz D (1983) Research on the treatment of narcotic addiction. The state of the art. National Institute of Drug Abuse, Rockville
Dees SM, Dansereau DF, Simpson DD (1997) Mapping-enhanced drug abuse counseling: urinalysis results in the first year of methadone treatment. J Subst Abuse Treat 14: 45–54
Dolan K, Hall W, Wodak A (1998) The provision of methadone within prison settings. In: Ward J, Mattick RP, Hall W (eds) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam, pp 379–396
*Dole V, Nyswander M (1965) A medical treatment for diacetylmorphine (heroin) addiction. JAMA 193: 146–150
*Farrell M, Neeleman J, Gossop M, Griffiths P, Buning E, Finch E, Strang J (1996) Drug prevention. A review of the legislation, regulation and delivery of methadone in 12 member states of the European Union. Final report. Office for Official Publications of the European Communities, Brussels
Finnegan LP, Hagan T, Kaltenbach KA (1991) Scientific foundation of clinical practice: opiate use in pregnant women. Bull NY Acad Med 67: 223–239
Gossop M (1998) NTORS at one year. The National Treatment Outcome Research Study. Department of Health, London
Hartnoll R, Mitcheson M, Battersby A, Brown G, Ellis M, Fleming P, Hedley N (1980) Evaluation of heroin maintenance in a controlled trial. Arch Gen Psychiatr 37: 877–884
Hubbard RL, Marsden ME, Rachal JV, Haarwood HJ, Cavanaugh ER, Ginzburg HM (1989) Drug abuse treatment. A national study of effectiveness. University of North Carolina Press, Chapel Hill
Kreek MJ (1996) Long-term pharmacotherapy for opiate (primarily heroin) addiction: opioid agonists. In: Schuster CH, Kuhar MJ (eds) Pharmacological aspects of drug dependence. Toward an integrated neurobehavioral approach. Springer, Berlin Heidelberg New York, pp 487–562
Lifschitz MH, Wilson GS, Smith EO, Desmond MM (1985) Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 75: 269–274
Ling W, Klett JC, Gillis RC (1980) A cooperative clinical study of methadyl acetate. Arch Gen Psychiatry 37: 908–911
Maddux JF, Desmond DP, Esquivel M (1995) Rapid admission and retention on methadone. Am J Drug Alcohol Abuse 21: 533–547
Mattick RP, Oliphant D, Ward J, Hall W (1998) The effectiveness of other opioid replacement therapies: LAAM, heroin, buprenorphine, naltrexone and injectable maintenance. In Ward J, Mattick RP, Hall W (eds) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam, pp 123–160
*McLellan AT, Arndt IO, Metzger IS, Woody GE, O’Brien CP (1993) The effects of psychosocial services in substance abuse treatment. JAMA 269: 1953–1959
Metrebian N, Shanahan W, Wells B, Stimson GV (1998) Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: associated health gains and harm reductions. Med J Aust 168: 596–600
Mino A (1990) Analyse scientifique de la litérature sur la remise contrôlée d’héroïne ou de morphine. Institutions universitaires de psychiatrie, Geneva
Parrino MW (1991) State methadone treatment guidelines. U.S. Department of Health and Human Services, Rockville
*Raschke P (1994) Substitutionstherapie. Ergebnisse langfristiger Behandlung von Opiatabhängigen. Lambertus, Freiburg im Breisgau
Rhoades HM, Creson D, Elk R, Schmitz J, Grabowsk J (1998) Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health 88: 34–39
Robinson GM, Dukes PD, Robinson BJ, Cook RR, Mahoney GN (1993) The misuse of buprenorphine and buprenorphinenaloxone combination in Wellington, New Zealand. Drug Alcohol Dependence 33: 81–86
Ruel JM (1996) International survey on the use of methadone in the treatment of narcotic addiction. Bureau of Drug Surveillance, Ottawa
Savage C, Karp EG, Curran SF, Hanlon TE, McCabe OL (1976) Methadone/LAAM maintenance: a comparison study. Compr Psychiatry 17: 415–424
Scott RTA, Jay MJH, Keith R, Oliver JS, Cassidy MT (1999) A confidential enquiry into methadone-related deaths. Addiction 94: 1789–1794
*Seidenberg A, Honegger U (1998) Methadon, Heroin und andere Opioide. Medizinisches Manual für die ambulante opioidgestützte Behandlung. Huber, Bern
Senay EC, Uchtenhagen A (1990) Methadone in the treatment of opioid dependence. In: Arif A, Westermeyer J (eds) Methadone maintenance in the management of opioid dependence. Praeger, New York, pp 19–54
Senay EC, Barthwell A, Marks R, Bokos PJ (1994) Medical maintenance: an interim report. J Addict Di 13: 65–69
Simpson DD, Curry SJ (eds) (1997) Drug Abuse Treatment Outcome Study DATOS. Psychol Addict Behav 11 (special issue): 4
Simpson DD, Sells SB (1990) Opioid addiction and treatment: a 12-year follow-up. Krieger, Malabar
Simpson DD, Joe GW, Dansereau DF, Chatham LR (1997) Strategies for improving methadone treatment process and outcomes. J Drug Issues 27: 239–260
Stitzer ML, Iguchi MY, Felch LJ (1992) Contingent take-home incentive: effects on drug use of methadone. J Consulting Clin Psychol 60: 927–934
Strang J, Gossop M (1996) Heroin prescribing in the British system: a historical review. Eur Addict Res 2: 185–193
Svikis DS, Lee JH, Haug NA, Stitzer ML (1997) Attendance incentives for outpatient treatment: effects in methadoneand nonmethadone-maintained pregnant drug dependent women. Drug Alcohol Dependence 48: 33–41
Tennant FS, Rawson RA, Pumphrey E, Seecof R (1986) Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM). J Subst Abuse Treat 3: 195–202
*Uchtenhagen A, Zimmer-Höfler D (1985) Heroinabhängige und ihre normalen Altersgenossen. Herkunft, Lebenssituation, Zweijahresverlauf im Quervergleich. Haupt, Bern
Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Blättler R, Pfeifer S (1999) Prescription of narcotics for heroin addicts. Main results of the Swiss National Cohort Study. Karger, Basel
van Brüssel G (1995) Le programme de distribution de morphine a Amsterdam: experiences pratiques. In: Rihs-Middel M, Clerc J, Stamm R (eds) La préscription de stupéfiants sous contrôle médical. Editions Médecine et Hygiène, Geneva, pp 161–167
van Rhee JM (1998) Study on the effectiveness of medically coprescribed heroin. Progress report. Central Committee on the Treatment of Heroin Addicts, Utrecht
Verthein U, Degkwitz P, Haasen C, Raschke P, Krausz M (1996) Die Substitutionsbehandlung Opiatabhängiger mit Codein/ Dihydrocodein und Methadon ein Kontrollgruppenvergleich. Sucht 42: 108–115
Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE (1994) Clinical pharmacology of buprenorphine. Ceiling effects at high doses. Clin Pharmacol Ther 55: 569–580
*Ward J, Mattick R, Hall W (1998) Methadone maintenance treatment and other opioid replacement therapies. Harwood, Amsterdam
WHO (1989) Options for the use of methadone in the treatment of drug dependence. World Health Organization, Geneva (WHO/MNH/DAT/89/2)
WHO (1998) WHO Expert Committee on Drug Dependence. Thirtieth Report. World Health Organization, Geneva (Technical report series 873)
Woody GE, McLellan AT, Luborsky LO, Brien CP (1995) Psychotherapy in community methadone programs: a validation study. Am J Psychiatr 152: 1302–1308
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Uchtenhagen, A. (2001). Substitution Treatment for Opiate Dependence. In: Henn, F., Sartorius, N., Helmchen, H., Lauter, H. (eds) Contemporary Psychiatry. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59519-6_139
Download citation
DOI: https://doi.org/10.1007/978-3-642-59519-6_139
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64007-0
Online ISBN: 978-3-642-59519-6
eBook Packages: Springer Book Archive